Investor FAQ

Show All
Where is Sigilon Therapeutics’ corporate headquarters?
Sigilon is headquartered at 100 Binney St, STE 600, Cambridge, MA 02142.
Where is the company incorporated?
Sigilon Therapeutics is incorporated in Delaware, USA.
On what stock exchange are Sigilon shares traded, what is the ticker symbol and when did it go public?
Sigilon’s stock is traded on the NASDAQ Global Market under the symbol SGTX. Our initial public offering was in December 4, 2020.
When does Sigilon Therapeutics’ fiscal year end?
Our fiscal year ends on December 31.
Does Sigilon Therapeutics pay dividends?
Sigilon does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.
Who is Sigilon Therapeutics’ transfer agent?

Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
United States of America

Telephone Inquiries:
Toll Free: (800) 736 3001 (US, Canada, Puerto Rico)
Toll: (781) 575 3100 (non-US)

How can I update my address?
If your address has changed, please contact our transfer agent by visiting their website at:
How can I purchase shares?
Shares can be purchased through a stockbroker of your choice. Sigilon does not have a direct stock purchase plan.
Who are the company's independent auditors and legal counsel?

Our independent auditor is:

Price Waterhouse Cooper 
101 Seaport Blvd
Boston, MA 02210
+1 617 530 5000

Our legal counsel is:

Ropes and Gray LLP 
Prudential Tower
800 Boylston Street
Boston, MA 02199
+1 617 951 7000